HopeStage
Back to overview

Schizophrenia studies

Topics
More filters

Schizophrenia

Schizophrenia can affect how a person perceives reality, thinks and feels, sometimes involving hearing voices or holding unusual beliefs.

4505studies shown
Showing 2,413-2,424 of 4,505
Drug study icon
TerminatedNCT00658645

Efficacy of Bifeprunox in people with Schizophrenia

What is this study about?

Researchers are comparing Bifeprunox, placebo and Quetiapine to find out how the approaches affect psychotic symptoms in people with schizophrenia.

This study ended early.

Multiple locations, including Radnevo
SchizophreniaMedication studyAges 18–65
Countries
Bulgaria, China, Greece, + 5 others
Sponsor
H. Lundbeck A/S
Drug study icon
CompletedNCT00770744

Efficacy of Lu 31-130 in people with Schizophrenia

What is this study about?

Researchers compared Zicronapine and Olanzapine to find out how the approaches affected psychotic symptoms in people with schizophrenia.

This study has finished and is no longer accepting participants.

Multiple locations, including České Budějovice
SchizophreniaMedication studyAges 18–65
Countries
France, Czechia, China, + 5 others
Sponsor
H. Lundbeck A/S
Behavioral study icon
CompletedNCT03891186

Efficacy of Metacognitive Training for Schizophrenia - a Study Protocol

Official study title

A Randomized Controlled Trial to Evaluate the Efficacy of Metacognitive Training for Schizophrenia Applied by Mental Health Nurses: Study Protocol

This study has finished and is no longer accepting participants.

In Portalegre
SchizophreniaBehavioural studyAges 18–65
Countries
Portugal
Sponsor
University Rovira i Virgili
Behavioral study icon
CompletedNCT01279070

Efficacy of Repyflec Cognitive Remediation Group Training in Schizophrenia

Official study title

Efficacy of Repyflec Cognitive Remediation Group Training in Cognition, Functional Outcomes and Psychiatric Symptoms of Outpatients With Schizophrenia.

This study has finished and is no longer accepting participants.

In Sant Boi de Llobregat
SchizophreniaBehavioural studyAges 18–60
Countries
Spain
Sponsor
Fundació Sant Joan de Déu
Drug study icon
CompletedNCT00654706

Efficacy Study Exploring the Effects on Cognition of Sertindole Versus Comparator in people with Schizophrenia

What is this study about?

Researchers compared Sertindole and Quetiapine to find out how the approaches affected memory, attention and other thinking skills in people with schizophrenia.

This study has finished and is no longer accepting participants.

Multiple locations, including Garden Grove
SchizophreniaMedication studyAges 18–55
Countries
United States
Sponsor
H. Lundbeck A/S
Drug study icon
CompletedNCT01393613

Efficacy Study of OPC-34712 in Adults With Acute Schizophrenia

What is this study about?

Researchers compared OPC-34712 and placebo to find out how the approaches affected psychotic symptoms in adults with schizophrenia.

This study has finished and is no longer accepting participants.

Multiple locations, including Little Rock
SchizophreniaMedication studyAges 18–65
Countries
United States, Colombia, Croatia, + 5 others
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc. (Pharmaceutical company)
Drug study icon
CompletedNCT00784238

Efficacy Study of Paliperidone to Evaluate Subjective Change in Well-being and Drug Attitude in Schizophrenic Participants

Official study title

An Open-label, Prospective, Non-Comparative Study to Evaluate Subjective Well-Being and Responses in Patients With Schizophrenia Who Had Switched to Paliperidone Extended-Release Tablets

This study has finished and is no longer accepting participants.

Multiple locations, including Busan
SchizophreniaMedication studyAges 18–65
Countries
South Korea
Sponsor
Janssen Korea, Ltd., Korea

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.